Literature DB >> 6149161

Effects of growth hormone on lipogenesis and glucose oxidation in genetically GH-deficient mice.

N A Adamafio, F M Ng.   

Abstract

Late inhibitory effects of growth hormone were observed when the hormone (0.1-1.0 microgram/ml) was incubated with adipose tissue from GH-deficient and normal mice. Early insulin-like effects of GH occurred only when glucose was used as precursor. Adult GH-deficient mice have a much higher basal acetyl-CoA carboxylase activity than normal mice. Administration of GH caused a marked reduction of enzyme activity in both groups.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149161     DOI: 10.1016/0303-7207(84)90057-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  4 in total

1.  Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation.

Authors:  Laurie R Braun; Meghan N Feldpausch; Natalia Czerwonka; Martin Torriani; Steven K Grinspoon; Takara L Stanley
Journal:  Growth Horm IGF Res       Date:  2017-10-07       Impact factor: 2.372

2.  The inhibition of insulin action and glucose metabolism by porcine growth hormone in porcine adipocytes is not the result of any decrease in insulin binding or insulin receptor kinase activity.

Authors:  K A Magri; M Adamo; D Leroith; T D Etherton
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

3.  Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease.

Authors:  Chelsea S Pan; Julian J Weiss; Lindsay T Fourman; Colleen Buckless; Karen L Branch; Hang Lee; Martin Torriani; Madhusmita Misra; Takara L Stanley
Journal:  Clin Endocrinol (Oxf)       Date:  2020-10-10       Impact factor: 3.523

4.  Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.

Authors:  Takara L Stanley; Lindsay T Fourman; Isabel Zheng; Colin M McClure; Meghan N Feldpausch; Martin Torriani; Kathleen E Corey; Raymond T Chung; Hang Lee; David E Kleiner; Colleen M Hadigan; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.